ISMP (US) Contact Us Feedback
     Search:  
   

ISMP Canada News

April 28, 2021: Health Canada: Bamlanivimab – Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants


Health Canada: Bamlanivimab – Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants" trackback:ping="https://www.ismp-canada.org/news/bblog/trackback.php/501/" />

Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.